An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Drug Gaining Popularity Online
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the substance there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Voice Worries
Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting products of unknown origin.
Some experts stated the popularity for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer regulations, risking fines, legal action or prison.
Platform Response and Material Removal
Based on the social media company, the platform has removed problematic material and prohibited associated keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Digital Trading Activities
Research also found communities with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, glowing testimonials and detailed instructions for preparing or injecting at home.
Within moments of entering one community, a seller posted contact information, where most transactions occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.
Product Details and Costs
Within these groups, messages show black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A representative for Telegram stated it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they cannot confirm. Although the science behind this drug is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her team has already seen patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to possibly serious medical dangers”.
